Advertisement

Annals of Surgical Oncology

, Volume 25, Supplement 3, pp 757–758 | Cite as

ASO Author Reflections: Cost Effectiveness of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

  • Z. J. Lee
  • C. C. M. TeoEmail author
ASO Author Reflections
  • 43 Downloads

Notes

Disclosure

The authors have no conflicts of interest to disclose.

References

  1. 1.
    Lee ZJ, Chia SL, Tan G, Soo KC, Teo CCM. Cost effectiveness of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for management of colorectal peritoneal carcinomatosis. Ann Surg Oncol. 2018;25:2340–6.CrossRefGoogle Scholar
  2. 2.
    Tan WJ, et al. Quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: an Asian perspective. Ann Surg Oncol. 2013;20:4219–23.CrossRefGoogle Scholar
  3. 3.
    Chua TC, et al. Evaluation of the cost effectiveness of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (peritonectomy) at the St George Hospital peritoneal surface malignancy program. Ann Surg. 2010;251:323–9.CrossRefGoogle Scholar
  4. 4.
    Cashin PH, et al. Quality of life and cost effectiveness in a randomized trial of patients with colorectal cancer and peritoneal metastasis. Eur J Surg Oncol. 2018;44:983–90.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  1. 1.Division of Surgical OncologyNational Cancer Center SingaporeSingaporeSingapore

Personalised recommendations